Respiratory Distress syndrome
-Also known as Hyaline membrane disease
-Result of deficiency of mature functioning surfactant, and immature cellular and vascular development of the lung
RDS
-Pathophysiology
-Leads to reduced alveolar recruitment (atelectasis)
-Decreased FRC, decreased pulmonary compliance, increased pulmonary resistance, and ventilation perfusion mismatch
RDS
-Clinical presentation and diagnosis
refractory hypoxemia
-CXR, ground glass (retriculogranular infiltrates) air bronchograms -L/S ratio < 2:1
RDS
-Prevention
-Antenatal steroid therapy
RDS
-Treatment
caffeine citrate
-Surfactant Therapy
-4 Exogenous Surfactant Preparation currently used in U.S (All administered a little differently)
-Beractant (Survanta) (Bovine) dosed in 4 aliquots
-Calftant (Infassuft) (bovine) dosed in 2 aliquots -Poractant alpha (Curosurf) (Procine) dosed in 2 aliquots -Lucinactant (Surfaxin, aerosurf) (synthetic) dosed in 4 aliquots -Via an endotracheal tube -Most commonly administered in two aliquots
-Surfactant Therapy
ET Tube
-Via an endotracheal tube
-Most commonly administered in two aliquots -Methods of administration via ET tube -Infant in positioned to allow gravity to aid in distributing surfactant throughout the lung
-Surfactant Therapy
Suction time
-Infant should not be suctioned for 1-2 hours after administration unless serious obstruction present
Bronchopulmonary Dysplasia (BPD)
-A severe chronic lung injury in premature infants who survived hyaline membrane disease after treatment with mechanical ventilation and oxyge
Bronchopulmonary Dysplasia (BPD)
-Pathogensis (4 Major factors)
-Pathogensis
-4 Major factors in BPD pathogenesis -Lung immaturity, respiratory failure, oxygen supplementation, positive pressure mechanical ventilation
Bronchopulmonary Dysplasia (BPD)
-Prevention
-Avoidance of factors that predispose to injury
-Lung protective ventilatory strategies -Target oxygen saturation -Methylxanthines
Transient tachypnea of the newborn (TTN)
-Etiology may be secondary to fetal lung fluid retained after birth
-Near term or term infant -Most common after elective cesarean section delivered without labor
Transient tachypnea of the newborn (TTN)
-Clinical presentation and diagnosis
-Lung sounds may be diminished or have crackles on auscultation
-CXR, pulmonary vascular congestion,
Transient tachypnea of the newborn (TTN)
-Treatment
-CPAP levels of approximately 5 cmH2O may be needed
Neonatal Infections/ Pneumonia
-An infection caused by the bacteria Group B strep which may lead ri sepsis
-Risk factors
-Prematurity and low birth weight
Neonatal Infections/ Pneumonia
-Prevention & Treatment
-Prevention
-Aggressive management of suspected maternal chorioamnionitis a bacterial infection of amnion sac or amniotic fluid that occurs before or during labor -Rapid delivery of the infant -Treatment -Largly Supportive, antibiotic or antiviral therapy,
Meconium Aspiration Syndrome
-Meconium is the thick, black green tinged bowel content of a newborn.which is usually passed within 48 hrs after delivery
-Physical examination -Often revealed a newborn with yellow stained skin, nails, and cord and the postmature signs of peeling skin and long finger nails, respiratory distress, barrel chest
Meconium Aspiration Syndrome
-Prevention
-Prevention
-Prevention of postmature delivery by induction of labor at 41 weeks -Endotracheal intubation and intratracheal suction in the delivery room -Recommendation for intubation and tracheal suctioning has been removed
Meconium Aspiration Syndrome
-Compilactions and prognosis
-Ball valve effect
Persistent Pulmonary Hypertension of the Neonate (PPHN)
-A clinical syndrome that occurs as a result of disruption in the normal prenatal fetal neonatal circulatory transition
-Persistent fetal circulation (PFC) -Severe hypoxemia due to right to left shunt through foramen ovale and PDA
Persistent Pulmonary Hypertension of the Neonate (PPHN)
-Clinal presentation and diagnosis
-Symptoms usually appear within the 1st 24 hrs after birth
-Should be suspected in all term infants who are cyantic despite adequate ventilation
-Investiations
-CXS varies, echocardiography
Persistent Pulmonary Hypertension of the Neonate (PPHN)
-Pharmacotherapy
-Pharmacotherapy
-iNO -Oxygen index -Phosphodiesterase inhibitors -Prostacyclin analogs
Neonatal Apnea
-Apnea, an unexplained episode of cessation of breathing for 20 seconds or longer, or shorter respiratory pause associated with bradycardia cyanosis, pallor, or hypotonia
-Aonea or prematurity (AOP) a sudden cessation of breathing that last for at least 20 seconds or is accompanied by bradycardia or cyanosis in an infant younger than 37 weeks postmenstrual age -Apnea of infancy (AOI) infants with a postmenstrual age of 37 weeks or more at the onset of apnea
Neonatal Apnea
-Classification
-Classification, central, obstructive, and mixed
-Developmental immaturity of central respiratory drive is a key factor